Atrial Fibrillation: Emerging Atrial-Selective Antiarrhythmic Drugs are Poised to Address Major Unmet Needs in Treatment - On Demand

Decision Resources is offering this exclusive webinar, which is based on both our Pharmacor Atrial Fibrillation advisory service as well as our DecisionBase 2012 report entitled Emerging Atrial-Selective Antiarrhythmic Drugs are Poised to Address Major Unmet Needs in Atrial Fibrillation Treatment.

Date & Time
Recorded live on Wednesday, March 7, 2012
10 a.m. ET, 4 p.m. CET

Click here to view the invite.

To learn how you can access the recorded playback of this event, please fill out the following form and a representitive will contact you:


*First Name:
*Last Name:
 Job Title:
*Company:
 Phone:
*Country:
*Email Address:
 Comments:
*Agreement:
I have read and agree to abide by the Decision Resources Terms of Use and Privacy Policy.

*Required






Search Reports


Decision Resources Group brands include: